Fig. 4
From: Cyclin D1 immunohistochemical staining to separate benign from malignant mesothelial proliferations
One suggested approach to using BAP1, MTAP, and cyclin D1 immunostaining to separate epithelial mesotheliomas in the pleural cavity from reactive mesothelial proliferations when BAP1 and MTAP immunostaining are available. If BAP1 and/or MTAP are not available, starting with cyclin D1 is a reasonable alternative (see text)
